Tidal Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Sell |
5,574
-553
| -9% | -$180K | 0.01% | 745 |
|
|
2025
Q1 | $1.65M | Sell |
6,127
-7,061
| -54% | -$1.91M | 0.01% | 753 |
|
|
2024
Q4 | $3.1M | Sell |
13,188
-7,356
| -36% | -$1.73M | 0.02% | 510 |
|
|
2024
Q3 | $5.65M | Buy |
20,544
+8,811
| +75% | +$2.42M | 0.06% | 291 |
|
|
2024
Q2 | $2.85M | Buy |
11,733
+1,452
| +14% | +$353K | 0.04% | 402 |
|
|
2024
Q1 | $1.54M | Buy |
10,281
+7,660
| +292% | +$1.14M | 0.03% | 647 |
|
|
2023
Q4 | $502K | Buy |
2,621
+344
| +15% | +$65.8K | 0.01% | 925 |
|
|
2023
Q3 | $403K | Buy |
2,277
+56
| +3% | +$9.92K | 0.01% | 943 |
|
|
2023
Q2 | $422K | Sell |
2,221
-1,574
| -41% | -$299K | 0.01% | 903 |
|
|
2023
Q1 | $760K | Sell |
3,795
-473
| -11% | -$94.7K | 0.03% | 592 |
|
|
2022
Q4 | $1.01M | Buy |
4,268
+1,827
| +75% | +$434K | 0.04% | 442 |
|
|
2022
Q3 | $489K | Buy |
2,441
+633
| +35% | +$127K | 0.02% | 574 |
|
|
2022
Q2 | $264K | Sell |
1,808
-595
| -25% | -$86.9K | 0.01% | 829 |
|
|
2022
Q1 | $392K | Buy |
2,403
+222
| +10% | +$36.2K | 0.01% | 733 |
|
|
2021
Q4 | $370K | Sell |
2,181
-193
| -8% | -$32.7K | 0.01% | 705 |
|
|
2021
Q3 | $448K | Buy |
2,374
+373
| +19% | +$70.4K | 0.02% | 540 |
|
|
2021
Q2 | $339K | Buy |
+2,001
| New | +$339K | 0.01% | 534 |
|